Cincinnati Business Courier: Cincinnati Children’s lands third largest grant ever
UC faculty partner with Cincinnati Children's
Cincinnati Business Courier reports that Cincinnati Children’s has landed $28 million in federal funding – the hospital's third-largest single grant ever – to establish a data management and coordinating center for an agency that oversees researchers seeking cures for hundreds of rare diseases.
The five-year grant from the National Center for Advancing Translational Sciences, one of the National Institutes of Health, will fund a coordinating center to facilitate studies involving thousands of scientists across the United States and 22 other nations.
The center based at the hospital in Avondale will collect, organize, share and analyze big data about rare diseases that are often disabling or fatal. The data management and coordinating center will be led by three senior Children’s scientists and University of Cincinnati College of Medicine faculty members. They include Eileen King and Dr. Maurizio Macaluso, both professors in the UC Department of Pediatrics, and Peter White, professor and chair of the UC Department of Biomedical Informatics.
Read the Business Courier Story online
Learn more about how University of Cincinnati faculty will also support this work.
Photo courtesy of Cincinnati Children's
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.
Combination immunotherapy helps overcome melanoma treatment resistance
November 10, 2025
MSN highlighted research led by the University of Cincinnati Cancer Center's Trisha Wise-Draper showing a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory melanoma.